Product Program year 2024 Source: CMS Open Payments

Penta

Device Neuromodulation

PDI 05414734406246

Open in the dashboard

General payments

$2,209,563

3,209 payments

Research payments

$0

0 payments

Through program year 2024, $2,209,563 in general payments and $0 in research payments were reported against Penta (Neuromodulation).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2024 General $677,929 868
2023 General $761,383 1,201
2022 General $770,251 1,140

Breakdown

Who paid General payments · program years 2022–2024
  1. Abbott Laboratories $2,209,563 3,209 payments
Top recipients General payments · program year 2024
  1. Claudio Feler Neurological Surgery · Cheyenne, WY $644,234 95% · 4 payments
  2. Mercy Medical Center Teaching hospital · NY $4,946 <1% · 2 payments
  3. Matthew Ward Physician Assistant, Surgical · Henderson, NV $595 <1% · 27 payments
  4. James Forage Neurological Surgery · Henderson, NV $556 <1% · 27 payments
  5. Joshua Trbovich Physician Assistant · Washington, PA $542 <1% · 23 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Neurological Surgery $649,308 97% · 56 practitioners
  2. Physician Assistant $5,359 <1% · 38 practitioners
  3. Pain Medicine Anesthesiology $3,657 <1% · 28 practitioners
  4. Orthopaedic Surgery $2,990 <1% · 22 practitioners
  5. Orthopaedic Surgery of the Spine Orthopaedic Surgery $2,579 <1% · 28 practitioners

The top 5 of 31 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. Wyoming $644,234 95% · 1 recipient
  2. Pennsylvania $7,147 1% · 53 recipients
  3. Nevada $6,974 1% · 34 recipients
  4. New York $5,475 <1% · 11 recipients
  5. Texas $3,144 <1% · 30 recipients

The top 5 of 31 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

3,209 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record